Hypertrophic cardiomyopathy predominantly presented with obstructive and non-obstructive phenotypes, a notable genetic mutation burden, and low overall mortality primarily driven by heart failure.
In a large regional cohort of HCM patients, obstructive and non-obstructive phenotypes predominated with a notable genetic mutation burden and low overall mortality primarily driven by heart failure.
In this large regional cohort of HCM patients, obstructive and non-obstructive phenotypes were predominant, with a notable burden of genetic mutations and a low overall mortality rate primarily driven by heart failure. These findings emphasize the clinical heterogeneity of HCM and highlight the importance of comprehensive diagnostic evaluation.
Guler et al. (2026) studied this question. Hypertrophic cardiomyopathy predominantly presented with obstructive and non-obstructive phenotypes, a notable genetic mutation burden, and low overall mortality primarily driven by heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: